Hyperlipidemia Flashcards
Hyperlipidemia
Elevated TG & total cholesterol
Cholesterol forms what?
Forms steroid hormones/bile acids.
Triglyceride function
Transfers energy from food to cells.
Lipoproteins
Transfer lipids via apoproteins.
Low density: High TG.
High density: High apoproteins.
Two types of lipids
Cholesterol & TG
VLDL physio/pathway
- Made in liver
- VLDL transfers TG to cells
- Turns into LDL.
- LDL transfers cholesterol to cells
- Excess taken by liver & excreted via bile
HDL physio/path
Made in liver & intestine.
Collects LDL from plaques & cells and transfers to liver.
CVD (Cardiovascular disease/ASCVD)
CHD, Cerebrovascular, Peripheral artery, aortic atherosclerosis, AAA, TAA.
Primary HLD
Genetic abnormality due to cholesterol metabolism
Secondary HLD
Due to: DM, Alcohol, Renal ds, Cholestatic liver ds, Meds, Obesity/diet/sedentary
Medications causing secondary HLD
- OCP
- Thiazide diuretics
- Beta-blockers
- Atypical antipsychotics
Components measured
Total cholesterol & HDL
VLDL calculation
(TG/5)
LDL calculation
Total cholesterol-HDL-(TG/5)
LDL estimation incorrect if…
TG are above 200
Causes of abnormal cholesterol metabolism
- Genetic
- Insulin Resistance
- Organ dysfunction
Plaque formation
- LDL sticks to artery wall
- LDL oxidized (Pro-inflammatory & thrombotic)
- Macrophages eat lipids= Foam cells
- Endothelial dysfunction
- Vasoconstriction leads to exertional angina
- Plaque ruptures leads to MI/TIA/CVA
Non-modifiable risk factors
- M>45, F>55
- Male
- Premature family hx
(M<55, F<65, 1st degree)
Modifiable risk factors
- Dyslipidemia, Low HDL,
- HTN
- Alcohol/smoking/diet
- DM
- PAD
- Renal ds
Under 65, what % dx/death
- Dx: 50%
2. Death: 15%
Hard Coronary Framingham risk
10 year risk of MI/death
Takes into account: Age, sex, smoke, Cholesterol, HDL, SBP, Tx.
ACC/AHA risk score
10 year risk of Heart disease/stroke
Takes into account: same + Race, DBP, Diabetes
High LDL/HDL relationship with ASCVD
High LDL high ASCVD
Decrease 1% LDL, Decrease CVD 1-1.5%
High HDL low ASCVD
Increase 2-3% HDL, Decrease CVD 2-4%
Primary vs Secondary prevention
Primary: modest benefits
Secondary: Strong benefits (if already had event)
Physical exam signs
Xanthomatous tendons (Plaques on knuckles/elbows)
Xanthelasma (plaques on eyelids)
Corneal arcus
Lipemia retinalis (white arteries on retina)
Eruptive xanthomas
NCEP ATP III 9 steps
- Fasting lipid panel
- CHD risk equivalent
- Major risk factors
- Framingham risk (if 2+ rf/CHD equiv)
>20%=CHD risk equivalent - Determine LDL goal dependent on risk category
6.TLC - Drug therapy for LDL
- Metabolic syndrome after 3 mo (ID&treat)
- Treat TG/HDL
Optimal fasting levels
- Total: less than 200
- LDL: less than 70
- HDL: greater than 40, greater than 50 for women
CHD equivalent
- Coronary artery disease
- Peripheral artery disease
- AAA
- Diabetes
Major risk factors
- Smoking
- HTN
- HDL <40
- Family hx premature CAD
- Men>45, Women>55
LDL goals for categories
- CHD/Equivalent: <70
- 2+ risk factors: <100
- 0-1 risk factors: <160
TLC & effect on LDL
- Low fat diet (<30% calories)
- Cholesterol <200 daily
- Increase viscous fiber (10-25g)
- Plant stanols/sterols
- Weight management
Decrease LDL 25-30%
When to initiate drug therapy?
After 3 months of TLC, LDL still high
Metabolic syndrome (3 of 5)
- Abdominal obesity (40M, 35W)
- TG > 150
- Low HDL
- Elevated BP
- Fasting glucose >100
TG values
- Normal: <150
- Mild hypertrig: 200-499
- Moderate/Risk for pancreatitis: >500
- Large risk for pancreatitis: >1000
ACC/AHA screening
> 21 yo, every 5 years for low to moderate risk
More frequent for high risk
ACC/AHA: Who to treat with statin?
- ASCVD
- LDL>190
- Diabetes: age 40-75, LDL >70
- 10 year risk >7.5%, age 40-75
High intensity treatment medication.
- Atorvastatin 40/80
- Rosuvastatin 20/40
(Decrease LDL 50%)
Who to treat high intensity?
- ASCVD up to age 75
- LDL > 190
- Diabetes, age 40-75, LDL >70, >7.5% risk
Moderate intensity treatment medication.
- Atorvastatin 10-20
- Simvastatin 20-40
- Pravastatin 40
(Decrease LDL 30-50%)
Who to treat moderate intensity?
- Age over 75
2. 40-75 yo, DM, LDL 70-189, 5-7.5% risk
Statin MOA
Decrease rate limiting enzyme for cholesterol formation in cells.
HMG-CoA reductase inhibitor.
Statin benefits/lipid effects
Decrease all cause mortality Decrease MI & CVA LDL 20-55% TG 7-30% HDL 5-15%
Statin CI
- Pregnancy/Breastfeeding
- Liver disease/Unexplained LFT increase
(Get baseline LFT)
Not effective: TG>400
Most effective: dose at night.
Statin side effects
- Myalgias
- Rhabdomyolysis/Myopathy (check CK if at risk)
- Hepatotoxicity (Check baseline LFT)
- Increase risk for DM
Cholesterol absorption inhibitor: MOA
Decrease absorption in intestine.
Increase LDL receptors peripherally.
Cholesterol absorption inhibitor: Lipid effects
LDL 15-20%
Cholesterol absorption inhibitor: CI
- With fibrates
2. Hepatic impairment
Fibric acid derivates: MOA & names
Increase VLDL breakdown, decrease synthesis
Gemfibrozil, Fenofibrate
Fibric acid derivates: Lipid effects
Drug of choice for TG>500
TG 40%
LDL 10-15%
HDL 15-20%
Fibric acid derivates: Side effects
- Cholelithiasis
- Hepatits
- Myositis
Fibric acid derivates: CI
- Gallbaldder ds
- Liver ds
- Caution-Pregnancy & Renal ds
- With Statin
Niacin: MOA
Decrease VLDL production
Niacin: Lipid effects
Good for very low HDL/mod high LDL
HDL 25-35%
LDL 15-25%
TG 50%
Niacin: Side effects
Flushing
Long acting better tolerated
Niacin: CI
- Pregnancy
- Liver ds
- Peptic ulcer
- Caution: Gout & DM
Bile-acid binding resins: MOA/Names
Binds bile acids in intestine.
Decreases bile acids in entero-hepatic system.
Liver increases bile acid production.
Uses up cholesterol.
Names: Chole- Cole-
Bile-acid binding resins: Lipid effects/who to us it in
LDL 15-25%
HDL insig
TG little/may increase
SAFE in pregnancy
Good for mod LDL & normal HDL/TG
Bile-acid binding resins: side effects
GI upset/constipation
Bile-acid binding resins: CI
- GI obstruction
- Hypertriglyceridemia
- Pancreatitis
PCSK9 Inhibitor: MOA
Blocks LDL receptor degradation.
Is a monoclonal ab
PCSK9 Inhibitor: Lipid effects, who to use
LDL 50-60%
Good for familial HLD
Omega-3 fatty acids benefits
Improves TG, decreases CV, anti-inflammatory
Familial hypercholesterolemia
LDL receptor dysfxn/gone
- Homo: LDL 8X, childhood
- Hetero: LDL 2X, 30s
Familial hyperchylomicronemia
Abnormal lipoprotein lipase (enzyme allows tisue to take TG from VLDL/chylomicrons)
Severe TG